0001610717-24-000228.txt : 20240501
0001610717-24-000228.hdr.sgml : 20240501
20240501195948
ACCESSION NUMBER: 0001610717-24-000228
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240429
FILED AS OF DATE: 20240501
DATE AS OF CHANGE: 20240501
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAAB MICHAEL
CENTRAL INDEX KEY: 0001321402
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36485
FILM NUMBER: 24904751
MAIL ADDRESS:
STREET 1: 1119 ST PAUL STREET
CITY: BALTIMORE
STATE: MD
ZIP: 21202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARDELYX, INC.
CENTRAL INDEX KEY: 0001437402
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 510-745-7047
MAIL ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
FORMER COMPANY:
FORMER CONFORMED NAME: NTERYX INC
DATE OF NAME CHANGE: 20080611
4
1
form4.xml
X0508
4
2024-04-29
0001437402
ARDELYX, INC.
ARDX
0001321402
RAAB MICHAEL
C/O ARDELYX, INC.
400 FIFTH AVENUE, SUITE 210
WALTHAM
MA
02451
true
true
President & CEO
true
Common Stock
2024-04-29
4
M
0
30000
0.99
A
1340933
D
Common Stock
2024-04-29
4
S
0
30000
6.4019
D
1310933
D
Common Stock
24364
I
Family Trust
Common Stock
1000
I
Family Trust
Stock Option (Right to Buy)
0.99
2024-04-29
4
M
0
30000
0
D
2032-01-06
Common Stock
30000
670000
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 13, 2023.
This transaction was executed in multiple trades in prices ranging from $6.311 to $6.49, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The shares are directly held by Michael G. Raab, Trustee of the Michael G. Raab Living Trust dated July 25, 2012.
The shares are owned directly by trusts for the benefit of the Reporting Person's children.
The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
/s/ Elizabeth Grammer, Attorney-in-Fact for Michael Raab
2024-05-01